Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Breast Cancer Genomics and Immunotherapy

Sherene Loi

MBBS, PhD

🏢Peter MacCallum Cancer Centre🌐Australia

Professor and Head of Translational Breast Cancer Research

71
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Sherene Loi is an internationally recognized breast cancer researcher whose work bridges genomics, immunology, and clinical translation. She has contributed to understanding immune infiltrates (TILs) as predictive biomarkers in breast cancer and to PI3K pathway alterations in HR+ disease. Her laboratory investigates mechanisms of CDK4/6 inhibitor resistance through comprehensive molecular profiling. She leads translational research programs in Australia and has been recognized with multiple international awards for her contributions to breast cancer science.

Share:

🧪Research Fields 研究领域

breast cancer genomics
tumor infiltrating lymphocytes
PI3K pathway
CDK4/6 resistance
immunotherapy in breast cancer

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-03-01 | All information from publicly available academic sources

关注 Sherene Loi 的研究动态

Follow Sherene Loi's research updates

留下邮箱,当我们发布与 Sherene Loi(Peter MacCallum Cancer Centre)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment